1-(2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indol-8-yl)-4-[(5-fluoro-2-pyridinyl)methoxy]pyridin-2-one;1-(2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indol-8-yl)-4-(4-methylphenyl)pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-[(2,4-difluorophenyl)methoxy]pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-(4-methylphenyl)pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-(6-methyl-3-pyridinyl)pyridin-2-one
C128H120F3N17O7 — CID 157133861
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indol-8-yl)-4-[(5-fluoro-2-pyridinyl)methoxy]pyridin-2-one;1-(2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indol-8-yl)-4-(4-methylphenyl)pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-[(2,4-difluorophenyl)methoxy]pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-(4-methylphenyl)pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-(6-methyl-3-pyridinyl)pyridin-2-one
1-(2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indol-8-yl)-4-[(5-fluoro-2-pyridinyl)methoxy]pyridin-2-one;1-(2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indol-8-yl)-4-(4-methylphenyl)pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-[(2,4-difluorophenyl)methoxy]pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-(4-methylphenyl)pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-(6-methyl-3-pyridinyl)pyridin-2-one (PubChem CID 157133861) has the molecular formula C128H120F3N17O7 and a molecular weight of 2065.47 g/mol. Its IUPAC name is 1-(2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indol-8-yl)-4-[(5-fluoro-2-pyridinyl)methoxy]pyridin-2-one;1-(2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indol-8-yl)-4-(4-methylphenyl)pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-[(2,4-difluorophenyl)methoxy]pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-(4-methylphenyl)pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-(6-methyl-3-pyridinyl)pyridin-2-one.
Molecular Properties
| Compound Name | 1-(2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indol-8-yl)-4-[(5-fluoro-2-pyridinyl)methoxy]pyridin-2-one;1-(2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indol-8-yl)-4-(4-methylphenyl)pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-[(2,4-difluorophenyl)methoxy]pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-(4-methylphenyl)pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-(6-methyl-3-pyridinyl)pyridin-2-one |
|---|---|
| PubChem CID | 157133861 |
| Molecular Formula | C128H120F3N17O7 |
| Molecular Weight | 2065.47 g/mol |
| Exact Mass | 2063.95 |
| IUPAC Name | 1-(2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indol-8-yl)-4-[(5-fluoro-2-pyridinyl)methoxy]pyridin-2-one;1-(2,3,5,10,11,11a-hexahydro-1H-indolizino[7,6-b]indol-8-yl)-4-(4-methylphenyl)pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-[(2,4-difluorophenyl)methoxy]pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-(4-methylphenyl)pyridin-2-one;1-(2,3,5,6,7,11c-hexahydro-1H-indolizino[7,8-b]indol-9-yl)-4-(6-methyl-3-pyridinyl)pyridin-2-one |
| SMILES | Cc1ccc(-c2ccn(-c3ccc4c5c([nH]c4c3)CC3CCCN3C5)c(=O)c2)cc1.Cc1ccc(-c2ccn(-c3ccc4c5c([nH]c4c3)CCN3CCCC53)c(=O)c2)cc1.Cc1ccc(-c2ccn(-c3ccc4c5c([nH]c4c3)CCN3CCCC53)c(=O)c2)cn1.O=c1cc(OCc2ccc(F)cc2F)ccn1-c1ccc2c3c([nH]c2c1)CCN1CCCC31.O=c1cc(OCc2ccc(F)cn2)ccn1-c1ccc2c3c([nH]c2c1)CC1CCCN1C3 |
| InChI | InChI=1S/C26H23F2N3O2.2C26H25N3O.C25H23FN4O2.C25H24N4O/c27-17-4-3-16(21(28)12-17)15-33-19-7-11-31(25(32)14-19)18-5-6-20-23(13-18)29-22-8-10-30-9-1-2-24(30)26(20)22;1-17-4-6-18(7-5-17)19-10-14-29(25(30)15-19)20-8-9-21-23(16-20)27-22-11-13-28-12-2-3-24(28)26(21)22;1-17-4-6-18(7-5-17)19-10-12-29(26(30)13-19)21-8-9-22-23-16-28-11-2-3-20(28)14-25(23)27-24(22)15-21;26-16-3-4-17(27-13-16)15-32-20-7-9-30(25(31)12-20)19-5-6-21-22-14-29-8-1-2-18(29)10-24(22)28-23(21)11-19;1-16-4-5-18(15-26-16)17-8-12-29(24(30)13-17)19-6-7-20-22(14-19)27-21-9-11-28-10-2-3-23(28)25(20)21/h3-7,11-14,24,29H,1-2,8-10,15H2;4-10,14-16,24,27H,2-3,11-13H2,1H3;4-10,12-13,15,20,27H,2-3,11,14,16H2,1H3;3-7,9,11-13,18,28H,1-2,8,10,14-15H2;4-8,12-15,23,27H,2-3,9-11H2,1H3 |
| InChIKey | AJJUFZPMFRFITC-UHFFFAOYSA-N |
| XLogP | 23.01 |
| TPSA | 249.39 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 19 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 155 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2065.47 |
| LogP ≤ 5 | 23.01 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 19 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157133861 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.